チロシン血症
WordNet
- autosomal recessive defect in tyrosine metabolism resulting in liver and kidney disturbances and mental retardation
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/03/01 01:39:25」(JST)
[Wiki en表示]
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2007) |
Tyrosinemia |
Tyrosine
|
Classification and external resources |
ICD-10 |
E70.2 |
ICD-9 |
270.2 |
OMIM |
276700 276600 276710 |
DiseasesDB |
13478 13486 29836 |
eMedicine |
ped/2339 |
Patient UK |
Tyrosinemia |
MeSH |
D020176 |
Tyrosinemia (or "Tyrosinaemia") is an error of metabolism, usually inborn, in which the body cannot effectively break down the amino acid tyrosine. Symptoms include liver and kidney disturbances and mental retardation. Untreated, tyrosinemia can be fatal.
Most inborn forms of tyrosinemia produce hypertyrosinemia (high levels of tyrosine).[1]
Contents
- 1 Types
- 2 Treatment
- 3 See also
- 4 References
- 5 External links
Types
Tyrosinemia is inherited in an autosomal recessive pattern.
There are three types of tyrosinemia, each with distinctive symptoms and caused by the deficiency of a different enzyme.
- Type I tyrosinemia
- Type II tyrosinemia
- Type III tyrosinemia
Pathophysiology of metabolic disorders of tyrosine, resulting in elevated levels of tyrosine in blood.
Treatment
Treatment varies depending on the specific type. A low protein diet may be required in the management of tyrosinemia. Recent experience with NTBC has shown to be very effective. The most effective treatment in patients with tyrosinemia type I seems to be full or partial liver transplant.
See also
- Alkaptonuria
- Inborn error of metabolism
- Ochronosis
References
- ^ Charles Scriver, Beaudet, A.L., Valle, D., Sly, W.S., Vogelstein, B., Childs, B., Kinzler, K.W. (Accessed 2007). The Online Metabolic and Molecular Bases of Inherited Disease. Chapter 79. New York: McGraw-Hill.
External links
- GeneReview/NCBI/NIH/UW entry on Tyrosinemia Type 1
- University of Washington
Inborn error of amino acid metabolism (E70–E72, 270)
|
|
K→acetyl-CoA |
Lysine/straight chain
|
- Glutaric acidemia type 1
- type 2
- Hyperlysinemia
- Pipecolic acidemia
- Saccharopinuria
|
|
Leucine
|
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
- 3-Methylcrotonyl-CoA carboxylase deficiency
- 3-Methylglutaconic aciduria 1
- Isovaleric acidemia
- Maple syrup urine disease
|
|
Tryptophan
|
|
|
|
G |
G→pyruvate→citrate
|
Glycine
|
- D-Glyceric acidemia
- Glutathione synthetase deficiency
- Sarcosinemia
- Glycine→Creatine: GAMT deficiency
- Glycine encephalopathy
|
|
|
G→glutamate→
α-ketoglutarate
|
Histidine
|
- Carnosinemia
- Histidinemia
- Urocanic aciduria
|
|
Proline
|
- Hyperprolinemia
- Prolidase deficiency
|
|
Glutamate/glutamine
|
|
|
|
G→propionyl-CoA→
succinyl-CoA
|
Valine
|
- Hypervalinemia
- Isobutyryl-CoA dehydrogenase deficiency
- Maple syrup urine disease
|
|
Isoleucine
|
- 2-Methylbutyryl-CoA dehydrogenase deficiency
- Beta-ketothiolase deficiency
- Maple syrup urine disease
|
|
Methionine
|
- Cystathioninuria
- Homocystinuria
- Hypermethioninemia
|
|
General BC/OA
|
- Methylmalonic acidemia
- Methylmalonyl-CoA mutase deficiency
- Propionic acidemia
|
|
|
G→fumarate
|
Phenylalanine/tyrosine
|
Phenylketonuria
|
- 6-Pyruvoyltetrahydropterin synthase deficiency
- Tetrahydrobiopterin deficiency
|
|
Tyrosinemia
|
- Alkaptonuria/Ochronosis
- Type I tyrosinemia
- Type II tyrosinemia
- Type III tyrosinemia/Hawkinsinuria
|
|
Tyrosine→Melanin
|
- Albinism: Ocular albinism (1)
- Oculocutaneous albinism (Hermansky–Pudlak syndrome)
- Waardenburg syndrome
|
|
Tyrosine→Norepinephrine
|
- Dopamine beta hydroxylase deficiency
- reverse: Brunner syndrome
|
|
|
|
G→oxaloacetate
|
Urea cycle/Hyperammonemia
(arginine
|
- Argininemia
- Argininosuccinic aciduria
- Carbamoyl phosphate synthetase I deficiency
- Citrullinemia
- N-Acetylglutamate synthase deficiency
- Ornithine transcarbamylase deficiency/translocase deficiency
|
|
|
|
Transport/
IE of RTT |
- Solute carrier family: Cystinuria
- Hartnup disease
- Iminoglycinuria
- Lysinuric protein intolerance
- Fanconi syndrome: Oculocerebrorenal syndrome
- Cystinosis
|
|
Other |
- 2-Hydroxyglutaric aciduria
- Aminoacylase 1 deficiency
- Ethylmalonic encephalopathy
- Fumarase deficiency
- Trimethylaminuria
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- glycolysis
- glycogenesis and glycogenolysis
- fructose and galactose
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- lipid
- phospholipid
- cholesterol and steroid
- lipoprotein
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- heme and porphyrin
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Carbohydrate
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Lipid
- Lipid storage
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Stereotactic Radiofrequency Ablation for Liver Tumors in Inherited Metabolic Disorders.
- Karall D, Scholl-Bürgi S, Widmann G, Albrecht U, Niedermayr K, Maurer K, Ausserer B, Huemer M, Bale R.SourceDepartment of Pediatrics I, Inherited Metabolic Disorders, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria, daniela.karall@i-med.ac.at.
- Cardiovascular and interventional radiology.Cardiovasc Intervent Radiol.2013 Oct 23. [Epub ahead of print]
- PURPOSE: Both glycogen storage disease type Ia (GSD Ia) and tyrosinemia type I (TYR I) are inherited metabolic disorders that can be complicated by formation of liver adenomas in juvenile/young adult age and/or development of hepatocellular carcinoma. We describe the first application of stereotacti
- PMID 24149831
- Childhood hepatocellular carcinoma: A clinicopathologic study of 12 cases with special reference to EpCAM.
- Zen Y, Vara R, Portmann B, Hadzic N.SourceHistopathology Section, Institute of Liver Studies, King's College Hospital, London, UK.
- Histopathology.Histopathology.2013 Oct 19. doi: 10.1111/his.12312. [Epub ahead of print]
- AIMS: To elucidate characteristics of hepatocellular carcinoma (HCC) in children.METHODS AND RESULTS: A retrospective search of our database identified 12 children with HCC (10 months to 11 years of age; M/F=5/7). Their pathologic features were compared with adult HCCs (n=20), fibrolamellar HCCs (n=
- PMID 24138022
- Effect of Acute Administration of L-Tyrosine on Oxidative Stress Parameters in Brain of Young Rats.
- Macêdo LG, Carvalho-Silva M, Ferreira GK, Vieira JS, Olegário N, Gonçalves RC, Vuolo FS, Ferreira GC, Schuck PF, Dal-Pizzol F, Streck EL.SourceLaboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Av. Universitária 1105, Criciúma, SC, 88806-000, Brazil.
- Neurochemical research.Neurochem Res.2013 Oct 18. [Epub ahead of print]
- Tyrosinemia type II, also known as Richner-Hanhart syndrome, is an autosomal recessive inborn error of metabolism caused by a deficiency of hepatic cytosolic tyrosine aminotransferase, and is associated with neurologic and development difficulties in numerous patients. Considering that the mechanism
- PMID 24135880
Japanese Journal
- Proceedings of the Japan Academy, Series B 88(5), 192-200, 2012
- … In 1957 Sakai and Kitagawa in Japan reported the clinical and biochemical findings in a patient with tyrosinemia, tyrosyluria, liver cirrhosis, and renal rickets. … Subsequently, reports were published from various countries of other patients with hepatorenal tyrosinemia (HRT). …
- NAID 130001924745
- Comparison of plasma and dry blood spots as samples for the determination of nitisinone (NTBC) by high-performance liquid chromatography-tandem mass spectrometry. Study of the stability of the samples at different temperatures
- PRIETO Jose A.,ANDRADE Fernando,LAGE Sergio,ALDAMIZ-ECHEVARRIA Luis
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 879(11), 671-676, 2011-04-01
- NAID 10029518345
- Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patients
- HEREBIAN Diran,SPIEKERKOTTER Ute,LAMSHOFT Marc,THIMM Eva,LARYEA Maurice,MAYATEPEK Ertan
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 877(14), 1453-1459, 2009-05-15
- NAID 10028017531
Related Links
- Tyrosinemia (or "Tyrosinaemia") is an error of metabolism, usually inborn, in which the body cannot effectively break down the amino acid tyrosine. Symptoms include liver and kidney disturbances and mental retardation. Untreated ...
Related Pictures
★リンクテーブル★
[★]
- 英
- aminoacidopathy, disorder of aminoacid metabolism disorders of amino acid metabolism
- 同
- アミノ酸代謝異常、先天性アミノ酸代謝異常症 先天性アミノ酸代謝異常 inborn error of amino acid metabolism
[show details]
アミノ酸代謝異常症
- 国試で出たことが有るレベル
アミノ酸代謝異常で痙攣を呈さないもの
[★]
- 英
- tyrosinemia
- 同
- 高チロシン血症 hypertyrosinemia
- 関
- アミノ酸代謝異常症
[show details]
[★]
遺伝性チロシン血症
- 関
- type I tyrosinemia、tyrosinemia
[★]
チロシン血症I型
- 関
- hereditary tyrosinemia、tyrosinemia